Kaia Health becomes World’s Most Broadly Covered Back Pain Offering after Gaining Approval for Prescription in Germany.
3 min read
New York, March 2, 2023 – Kaia Back Pain, a digital therapy for the treatment of non-specific back pain* has been permanently added to the Directory of Digital Health Applications (DiGA) by the German Federal Institute for Drugs and Medical Devices (BfArM), adding to the Kaia COPD DiGA listing in December. The digital therapy is available free of charge to Germans with statutory health insurance when prescribed.
Prof. Toelle, the chairman of the Rise-uP trial says: “The DiGA listing of the Kaia App is a milestone for the treatment of back pain and for digital medicine in Germany. The Rise-uP project started in 2016, long before digital health applications were in the medical scheme. Now, after 1200 patients in the study, 12 month observation, superior clinical outcome over a competitive control group, and skilled data on cost-savings we are starting the introduction as standard of care for non-specific back pain in the German health system. This means better, earlier and more efficient treatment for a broad sphere of patients”.
Nigel Ohrenstein, President of Kaia Health, says: “Kaia Health is committed to improving access to care for people suffering from chronic pain throughout the world, and as part of that we’re proud to bring our clinically validated and proven digital therapies to back pain sufferers in Germany, and at no cost to the patient”.
The Kaia App uses computer vision technology and artificial intelligence (AI) to support patients in performing their exercises. Using the device camera it analyzes movements in real-time to provide visual and verbal corrections – supporting the safe and correct execution of therapy for patients at home.
Kaia Back Pain effectively helps reduce pain and increase functional capacity and quality of life, among other things, according to evidence from the Rise-uP randomized-controlled trial. The primary endpoint and all secondary endpoints showed statistically significant positive clinical effects. The pain reduction was far above clinical relevance and confirms a long-term positive care effect from the use of DiGA.
Kaia Health is the world’s largest digital therapeutics company on a mission to empower millions of people to live their healthiest lives. Our evidence-based treatments, covering a range of conditions, including musculoskeletal pain and COPD, are powered by proprietary motion analysis technology and clinical expertise. No sensors or wearables are required, Kaia’s programs need only a smartphone to deliver the most accessible, effective, and equitable experience for all. Eleven clinical trials have shown Kaia’s effectiveness and safety to be as good as traditional care with up to 80% reduction in cost. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and is headquartered in NY and Munich. Kaia partners with leading health plans, employers, and providers, covering 60+ million lives around the world. Learn more at www.kaiahealth.com.